Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 45, 2013 - Issue 11
Submit an article Journal homepage
549
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Recurrent furunculosis: Efficacy of the CMC regimen — skin disinfection (chlorhexidine), local nasal antibiotic (mupirocin), and systemic antibiotic (clindamycin)

Benjamin DavidoFrom the Infectious Diseases Department, Raymond Poincaré Hospital, Paris Ile-de-France Ouest University, GarchesCorrespondence[email protected]
,
Aurélien DinhFrom the Infectious Diseases Department, Raymond Poincaré Hospital, Paris Ile-de-France Ouest University, Garches
,
Jérôme SalomonINSERM U657, PhEMI, Institut Pasteur, Paris
,
Anne Laure RouxMicrobiology Department, Raymond Poincaré Hospital, Paris Ile-de-France Ouest University, Garches
,
Marine Gosset-WoimantFrom the Infectious Diseases Department, Raymond Poincaré Hospital, Paris Ile-de-France Ouest University, Garches
,
Isabelle PierreFrom the Infectious Diseases Department, Raymond Poincaré Hospital, Paris Ile-de-France Ouest University, Garches
,
Christian PerronneFrom the Infectious Diseases Department, Raymond Poincaré Hospital, Paris Ile-de-France Ouest University, Garches
&
Louis BernardInfectious Diseases Department, Bretonneau Teaching Hospital, Tours, France
 show all
Pages 837-841 | Received 05 May 2013, Accepted 15 May 2013, Published online: 15 Jul 2013

References

  • Demos M, McLeod MP, Nouri K. Recurrent furunculosis: a review of the literature. Br J Dermatol 2012;167: 725–32.
  • Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. Chapter 22. In: Murray PR, Barron EJ, Pfaller MA, Tenover FC, Yolken RH, et al., editors. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology Press; 1995 pp 282–98.
  • Morgan M. Methicillin-resistant Staphylococcus aureus and animals: zoonosis or humanosis?J Antimicrob Chemother 2008;62:1181–7.
  • El-Gilany AH, Fathy H. Risk factors of recurrent furunculosis. Dermatol Online J 2009;15:16.
  • Wiese-Posselt M, Heuck D, Draeger A, Mielke M, Witte W, Ammon A, et al. Successful termination of a furunculosis outbreak due to lukS–lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002–2005. Clin Infect Dis 2007;44:e88–95.
  • Bernard P, Jarlier V, Santerre-Henriksen A. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections] (in French). Ann Dermatol Venereol 2008;135:13–9.
  • Jarlier V, Lorette G, Beaulieu P, Allaert FA, Mahmoudi A. Enquête épidémiologique nationale sur la prise en charge des infections cutanées bactériennes par le dermatologue. Epi'derm2. Paris: Congrès de Fédération Française de Formation Continue et d’Evaluation en Dermatologie; 2007.
  • Desenclos JC. RAISIN—a national programme for early warning, investigation and surveillance of healthcare- associated infection in France. Euro Surveill 2009;14(46). pii: 19408.
  • Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis 2008;197: 1226–34.
  • Kapusnik JE, Parenti F, Sande MA. The use of rifampicin in staphylococcal infections—a review. J Antimicrob Chemother 1984;13(Suppl C):61–6.
  • Hoss DM, Feder HM Jr. Addition of rifampin to conventional therapy for recurrent furunculosis. Arch Dermatol 1995;131:647–8.
  • L’Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM). Conférence de consensus “Prescription des antibiotiques par voie locale dans les infections cutanées bactériennes primitives et secondaires”. Paris: ANSM; 2004.
  • Raz R, Miron D, Colodner R, Staler Z, Samara Z, Keness Y. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med 1996;156:1109–12.
  • Wendt C, Schinke S, Württemberger M, Oberdorfer K, Bock-Hensley O, von Baum H. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2007;28:1036–43.
  • Atanaskova N, Tomecki KJ. Innovative management of recurrent furunculosis. Dermatol Clin 2010;28:479–87.
  • Groupe de Travail Cantonal CA-MRSA. Staphylocoques dorés communautaires résistant à la méticilline—recommandations destinées aux médecins du canton de Genève. Geneva: Groupe de Travail Cantonal CA-MRSA; 2004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.